1-6 of 6
Gareth J. Veal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer

Available to Purchase
Sarah Halford, Gareth J. Veal, Stephen R. Wedge, Geoffrey S. Payne, Chris M. Bacon, Philip Sloan, Ilaria Dragoni, Kathrin Heinzmann, Sarah Potter, Becky M. Salisbury, Maxime Chénard-Poirier, Alastair Greystoke, Elizabeth C. Howell, William A. Innes, Karen Morris, Chris Plummer, Mihaela Rata, George Petrides, Hector C. Keun, Udai Banerji, Ruth Plummer
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (8): 1429–1439.
https://doi.org/10.1158/1078-0432.CCR-22-2263
Published: 14 April 2023
View articletitled, A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
Open the PDF for A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer in another window
Includes: Supplementary data
Journal Articles

Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste

Free
Stuart J. Smith, Betty M. Tyler, Toby Gould, Gareth J. Veal, Noah Gorelick, Jonathan Rowlinson, Riccardo Serra, Alison Ritchie, Phillip Berry, Annette Otto, John Choi, Nicolas Skuli, Maria Estevez-Cebrero, Kevin M. Shakesheff, Henry Brem, Richard G. Grundy, Ruman Rahman
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (16): 5094–5106.
https://doi.org/10.1158/1078-0432.CCR-18-3850
Published: 15 August 2019
View articletitled, Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste
Open the PDF for Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste in another window
Includes: Supplementary data
Journal Articles

Adaptive Dosing Approaches to the Individualization of 13-Cis-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma

Free
Gareth J. Veal, Julie Errington, Sophie E. Rowbotham, Nicola A. Illingworth, Ghada Malik, Michael Cole, Ann K. Daly, Andrew D.J. Pearson, Alan V. Boddy
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (2): 469–479.
https://doi.org/10.1158/1078-0432.CCR-12-2225
Published: 16 January 2013
View articletitled, Adaptive Dosing Approaches to the Individualization of 13-Cis-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma
Open the PDF for Adaptive Dosing Approaches to the Individualization of 13-Cis-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Pharmacokinetics of Dactinomycin in a Pediatric Patient Population: a United Kingdom Children's Cancer Study Group Study

Free
Gareth J. Veal, Michael Cole, Julie Errington, Annie Parry, Juliet Hale, Andrew D.J. Pearson, Karen Howe, Julia C. Chisholm, Carol Beane, Bernadette Brennan, Fiona Waters, Adam Glaser, Sue Hemsworth, Heather McDowell, Yvonne Wright, Kathy Pritchard-Jones, Ross Pinkerton, Gail Jenner, James Nicholson, Ann M. Elsworth, Alan V. Boddy, UKCCSG Pharmacology Working Group
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5893–5899.
https://doi.org/10.1158/1078-0432.CCR-04-2546
Published: 22 August 2005
View articletitled, Pharmacokinetics of Dactinomycin in a Pediatric Patient Population: a United Kingdom Children's Cancer Study Group Study
Open the PDF for Pharmacokinetics of Dactinomycin in a Pediatric Patient Population: a United Kingdom Children's Cancer Study Group Study in another window
Journal Articles

A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia

Free
Brenda W. Cooper, Gareth J. Veal, Tomas Radivoyevitch, Michael J. Tilby, Howard J. Meyerson, Hillard M. Lazarus, Omer N. Koc, Richard J. Creger, Graham Pearson, Geoff M. Nowell, David Gosky, Stephen T. Ingalls, Charles L. Hoppel, Stanton L. Gerson
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6830–6839.
https://doi.org/10.1158/1078-0432.CCR-04-0097
Published: 22 October 2004
View articletitled, A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia
Open the PDF for A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia in another window
Journal Articles

Influence of Cellular Factors and Pharmacokinetics on the Formation of Platinum-DNA Adducts in Leukocytes of Children Receiving Cisplatin Therapy

Free
Gareth J. Veal, Cinara Dias, Lisa Price, Annie Parry, Julie Errington, Juliet Hale, Andrew D. J. Pearson, Alan V. Boddy, David R. Newell, Michael J. Tilby
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2205–2212.
Published: 01 August 2001
View articletitled, Influence of Cellular Factors and Pharmacokinetics on the Formation of Platinum-DNA Adducts in Leukocytes of Children Receiving Cisplatin Therapy
Open the PDF for Influence of Cellular Factors and Pharmacokinetics on the Formation of Platinum-DNA Adducts in Leukocytes of Children Receiving Cisplatin Therapy in another window